Access to new cholesterol-lowering drugs is so tightly controlled and patients’ out-of-pocket costs are so high that fewer than a third of those doctors prescribe the drugs get them, a new study found.
Access to new cholesterol-lowering drugs is so tightly controlled and patients’ out-of-pocket costs are so high that fewer than a third of those doctors prescribe the drugs get them, a new study found. Dreamstime TNS
Access to new cholesterol-lowering drugs is so tightly controlled and patients’ out-of-pocket costs are so high that fewer than a third of those doctors prescribe the drugs get them, a new study found. Dreamstime TNS

Out-of-pocket costs often keep pricey new cholesterol drugs out of reach, study finds

October 06, 2017 08:40 PM

UPDATED October 06, 2017 08:40 PM

More Videos

  • Marc Buoniconti signs copies of his book at Columbus High School

    Marc Buoniconti, who was paralyzed from the shoulders down in a football accident 32 years ago, spoke and signed copies on his new book at his alma mater, Christopher Columbus High.​